/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Hôpital Saint-Louis,.
/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced an expanded suite of.
Royal Bank of Canada assumed coverage on shares of SOPHiA GENETICS (NASDAQ:SOPH – Free Report) in a report released on Wednesday, MarketBeat.com reports. The firm issued an outperform rating and a $8.00 price objective on the stock. SOPHiA GENETICS Price Performance Shares of SOPH stock opened at $4.09 on Wednesday. The business’s 50-day moving average […]
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with the Città della Salute e della Scienza di Torino located in Turin, Italy. The hospital, which used SOPHiA GENETICS after a public tender in 2021 to optimize workflows and support research in the areas of hereditary cancer, neurological disorders, solid tumors, hematology and rare disease, will further expand its usage